Sergey Jakimov

Sergey Jakimov, Founding Partner at LongeVC, is a seasoned entrepreneur and venture capitalist specializing in biotech and longevity investments. In this engaging discussion, he emphasizes the importance of practical, science-backed approaches to longevity over hype. Sergey explains why aging isn’t classified as a disease, dives into AI's revolutionary impact on drug discovery, and highlights the burgeoning market of pet longevity. He also shares insights on how LongeVC evolved from a modest fund to raising $250M with an impressive record.